Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Germany flag Germany · Delayed Price · Currency is EUR
1.110
+0.020 (1.83%)
At close: Nov 27, 2025
20.65%
Market Cap701.10M
Revenue (ttm)89.95M
Net Income (ttm)3.81M
Shares Outn/a
EPS (ttm)0.01
PE Ratio184.15
Forward PE41.34
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open1.110
Previous Close1.090
Day's Range1.110 - 1.110
52-Week Range0.870 - 2.120
Betan/a
RSI40.63
Earnings DateNov 27, 2025

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 760
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol UJ9
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.